ECMC Annual Network Meeting - Wednesday 18 May 2016
Basic page
Agendas and Presentations Morning Plenary Session Agenda Reflection on the current quinquennium of the ECMC Network - Peter Johnson, Cancer Research UK Experience of the ECMC cross-centre placements and skills sharing scheme - Alan Bilsland, Glasgow and Karen Swales, ICR UK Therapeutic Cancer Prevention Network (UKTCPN) Update - Farhat Din,...
WISTERIA trial Spotlight
News
Q. Describe the trial and the anticipated patient benefit. The Birmingham ECMC WISTERIA Trial is a phase I dose-finding trial which will investigate whether it is safe and effective to combine a drug called AZD1775 with pre-surgery cisplatin and post-surgery cisplatin chemotherapy and radiotherapy in treating patients with head and...
SPIRE trial Spotlight
News
Q. Describe the trial and the anticipated patient benefit. This Southampton ECMC trial will combine a novel DNA methyltransferase inhibitor, SGI-110, with cisplatin and gemcitabine chemotherapy. This is based on pre-clinical data showing that hypomethylating agents can reverse cisplatin resistance mechanisms in a variety of solid malignancies, including bladder cancer...
Review of UCL/UCLH Public Cancer Research Open Day
Basic page
UCL ECMC co-ordinated the organisation and led the steering committee meetings for the UCL/UCLH Public Cancer Research Open Day which was held on Saturday 23rd April 2016. In total 95 members of public attended the event with almost 50 chaperons and volunteers helping out on the day. During the morning...
Review: Celebration of Cancer Nursing Event, Oxford
Basic page
The Oxford ECMC in collaboration with the Cancer Research UK Oxford Centre hosted a 'Celebration of Cancer Nursing Event at the Oxford University Hospitals NHS Foundation Trust" on World Cancer day. Danny Kelly, President of the European Oncology Nursing Society was the key note speaker. The event, which was attended...
Star studded night for TARGET fundraising
Basic page
Since the New Year The Christie charity has taken up the challenge of raising money for the precision medicine TARGET project which investigates liquid biopsies to inform decision making for precision medicine and has just come to the end of its third part and has to raise six hundred thousand...
Welcome to the ECMC Programme Office
Basic page
We are pleased to announce that the ECMC Secretariat has undergone a name change and will now be referred to as the ECMC Programme Office. This is to reflect the added functionality that the Programme Office will have moving forward, including more proactive engagement with industry to enhance delivery and...
Cancer Research UK and the Health Departments for England, Scotland, Wales, and Northern Ireland announce the renewal of the UK-wide early phase trial network
News
Following the recent review of the Adult and Paediatric ECMC Networks we are pleased to announce that we will be investing over £36 million into 18 adult locations across the UK, uniting world class cancer research and clinical expertise.
Interview with Harriet Walter
Interview
Dr Harriet Walter of Leicester ECMC is the chair of the Junior Investigator Network Group ( JING ), a group that supports junior investigators across the country develop through their early careers. We caught up with Harriet at the JING residential, to chat about why she got involved with JING...
JING goes from strength to strength
News
This year the ECMC Junior Investigators Network Group ( JING ) hosted its hugely successfully JING: Training the Next Generation residential in Glasgow. Now in its fifth year, the two-day meeting saw over 90 Network members come together to share their knowledge and experience in running early-phase clinical trials. JING...